Order Article Reprints

Basoulis D, Tsakanikas A, Gkoufa A, Bitsani A, Karamanakos G, Mastrogianni E, Georgakopoulou VE, Makrodimitri S, Voutsinas P-M, Lamprou P, et al. Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study. Viruses. 2023; 15(7):1515. https://doi.org/10.3390/v15071515

Basoulis, Dimitrios, Aristeidis Tsakanikas, Aikaterini Gkoufa, Aikaterini Bitsani, Georgios Karamanakos, Elpida Mastrogianni, Vasiliki E. Georgakopoulou, Sotiria Makrodimitri, Pantazis-Michail Voutsinas, Panagiota Lamprou, and et al. 2023. "Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study" Viruses 15, no. 7: 1515. https://doi.org/10.3390/v15071515

Basoulis, D., Tsakanikas, A., Gkoufa, A., Bitsani, A., Karamanakos, G., Mastrogianni, E., Georgakopoulou, V. E., Makrodimitri, S., Voutsinas, P.-M., Lamprou, P., Kontos, A., Tsiakas, S., Gamaletsou, M. N., Marinaki, S., & Sipsas, N. V. (2023). Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study. Viruses, 15(7), 1515. https://doi.org/10.3390/v15071515